期刊文献+

HPLC法测定达卡他韦原料药的含量及有关物质

Content and Impurity Determination of DCL by HPLC
下载PDF
导出
摘要 目的:采用HPLC法测定达卡他韦的含量及有关物质。方法:采用色谱柱Spursil-C18(25 cm×4.6 mm×5μm)为色谱柱,以0.01MKH2PO4∶TEA=1000∶0.5(H3PO4调pH为3.0)溶液为流动相A,乙腈为流动相B,以流动相A∶流动相B(70∶30)梯度洗脱,流速为1.0m L/min。稀释液为水∶乙腈=70∶30,检测波长为304 nm,柱温为35℃。结果:达卡他韦的线性范围为80~120μg/m L,3批样品中达卡他韦的含量分别为100.42%、100.29%、100.38%;有关物质A-C的线性范围分别为0.015%~0.30%。结论:本方法简便、准确,适用于达卡他韦含量及有关物质的测定。 Objective: To establish an HPLC method for assay determination of DCL. Method: adopt column Spursil-C18(25 cm×4.6 mm×5 μm) as analytical column, 0.01 MKH2 PO4:TEA=1000:0.5(H3 PO4 pH=3.0) solution as mobile phase A, Acetonitrile as mobile phase B, gradient elute mobile phase A and mobile phase B(70∶30)at a flow rate of 1.0 m L/min. The dilution should be water and Acetonitrile(70∶30) at the wavelength of 304 nm at the temperature of 35 ℃. Result: The linear range of DCL is 80-120 μg/m L, The linear range of Impurity A-C is 0.015 %-0.30 %, the DCL assay of 3 batches samples is 100.42 %, 100.29 %, 100.38 % respectively. Conclusion: above method is simple, accurate which is suitable for the assay and imputity determination of DCL.
作者 朱功凤 郑黎伟 孙海江 Zhu Gongfeng, Zheng Liwei, Sun Jianghai(Changzhou Pharmatech Co., Ltd., Changzhou 213018, Chin)
出处 《广东化工》 CAS 2018年第10期233-234,共2页 Guangdong Chemical Industry
关键词 达卡他韦 HPLC法 含量及有关物质测定 DCL HPLC method assay and impurity determination
  • 相关文献

参考文献2

二级参考文献4

  • 1FDA slaps down Bristol-Myers'marketing pitch for hep C drug daclatasvir(OL)http://www.fiercebiotech,com/story/fda-slaps-down-bristol-myers-marketing-pitch-hep-cdrug-daclatas virl2014-11-26.[2014-11-26].
  • 2Japan Approves First All-Oral,Interferon-and Ribavirin-Free Hepatitis C Treatment,Daklinza?(daclatasvir)and Sunvepra~?(asunaprevir)Dual Regimen[OL].http://news.bms.com/press-release/japan-approves-first-all-oral-interferon-and-ribavirin-freehepatitis-c-treatment-dakl.[2014-07-07].
  • 3Bristol-Myers Squibb Company(BMY)'s Hepatitis C Drug to Lose Special Breakthrough Status From the FDA[OL]http://www.biospace.com/News/bristol-myers-squibb-companyshepatitis-c-drug-tol364112.(2015-10-02).
  • 4歌礼丙肝新药ASC08二期临床试验数据发布[OL].http://www.prnasia.com/story/117330-1.shtml.[2015-03-18].

共引文献100

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部